EDITORIAL

BioBoard

Malaysia
•  Veolia expands presence in East Malaysia

Singapore
•  Syneron Dental Lasers signs distribution agreement with Healthcare Solutions & Services Pte Ltd
•  Fujitsu advances healthcare innovation in collaboration with National University of Singapore
•  Clearbridge BioMedics makes a big impact at the 2012 Asian Innovation Awards
•  TauRx Pharmaceuticals receives $111.8m commitment from Genting to prepare for Market Leadership in Alzheimer's

Thailand
•  Key Phase II HIV/HCV trial has commenced in Bangkok

Australia
•  Hatchtech mechanism of action data and safety study published
•  Power to you: carbon nanotube muscles are going strong

Europe
•  GE Healthcare Life Sciences opens new £3 million laboratories for cell science
•  AstraZeneca announces Phase III results from naloxegol pivotal trials
•  ACADIA’s pimavanserin sees Phase III success
•  Big Pharma is doing more for access to medicine in developing countries
•  CAVATAK^TM bladder cancer - positive preliminary data
•  Avita Medical initiates European trial in the management of chronic lower limb ulcers

North America
•  FEI unveils broad correlative microscopy solution set for cell biologists
•  A single dose of Medicago’s H5N1 VLP vaccine protects against additional pandemic flu strains in a preclinical study
•  Biologics and stem cell research boost the cell culture market

Eye on China
•  Fosun Pharmaceutical and Shanghai drugs open innovation model
•  QIAGEN gains SFDA approval to market careHPV Test
•  AstraZeneca’s heart drug wins approval
•  SIMM explores a novel cationic core-shell lipo-nanoparticles for ocular gene drug delivery
•  TaiGen and TTY Biopharm jointly develop and commercialize a novel topoisomerase I inhibitor DB67 for cancer treatment
•  iHuman Institute inauguration held
•  Sihuan Pharmaceutical collaborates with NeuroVive to develop two innovative cardio-cerebral vascular products
•  PerkinElmer acquires China-based infectious disease diagnostics company

Features
•  2013 – A Year of Access, Convergence and Technology
•  The Chinese Boom – Prediction for 2013
•  The IVD Market from an Investor’s Perspective
•  Changing Paradigms of the Pharma Industry: Global Economy or Tougher Regulatory Standards to Blame?
•  Neuroscience – The Search Continues

Review
•  Science Academies’ Role in Development: Presidents Reveal It All
•  Protein Nanocages: The Versatile Molecular Shell

Inside Industry
•  Dennis Gillings receives SCRIP Lifetime Achievement Award, Quintiles named CRO of the Year
•  IMCD to distribute TPE-S, TPE-V compounds
•  Selecta Biosciences and Sanofi sign global collaboration to develop antigen-specific immunotherapies
•  Verisante Aura named finalist for 2013 SPIE Prism Award
•  Direvo introduces BluCon™ for the conversion of non-food biomass to biofuel and chemical building blocks

•  Conference Calendar